ACS Chemical Biology editors highlight articles from Volume 9, Issue 5 and speak with authors Ernst Schonbrunn who reports a new structural framework for the development of next-generation BET-kinase inhibitors and Shanta Dhar regarding a new formulation for cancer treatment.